首页 > 最新文献

Journal of Pharmacopuncture最新文献

英文 中文
In Silico Studies of Indole Derivatives as Antibacterial Agents. 吲哚衍生物抗菌剂的硅片研究。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.147
Mridul Shah, Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Balasubramanian Narasimhan, Pradeep Kumar

Objectives: Molecular docking and QSAR studies of indole derivatives as antibacterial agents.

Methods: In this study, we used a multiple linear regressions (MLR) approach to construct a 2D quantitative structure activity relationship of 14 reported indole derivatives. It was performed on the reported antibacterial activity data of 14 compounds based on theoretical chemical descriptors to construct statistical models that link structural properties of indole derivatives to antibacterial activity. We have also performed molecular docking studies of same compounds by using Maestro module of Schrodinger. A set the molecular descriptors like hydrophobic, geometric, electronic and topological characters were calculated to represent the structural features of compounds. The conventional antibiotics sultamicillin and ampicillin were not used in the model development since their structures are different from those of the created compounds. Biological activity data was first translated into pMIC values (i.e. -log MIC) and used as a dependent variable in QSAR investigation.

Results: Compounds with high electronic energy and dipole moment were effective antibacterial agents against S. aureus, indole derivatives with lower κ2 values were excellent antibacterial agents against MRSA standard strain, and compounds with lower R value and a high 2χv value were effective antibacterial agents against MRSA isolate.

Conclusion: Compounds 12 and 2 showed better binding score against penicillin binding protein 2 and penicillin binding protein 2a respectively.

目的:吲哚类抗菌药物的分子对接及QSAR研究。方法:采用多元线性回归(MLR)方法对14种已报道的吲哚衍生物进行二维定量构效关系分析。基于理论化学描述符,对已报道的14种化合物的抑菌活性数据进行分析,建立了吲哚衍生物结构性质与抑菌活性之间的统计模型。我们还利用薛定谔的Maestro模块对相同的化合物进行了分子对接研究。计算了疏水、几何、电子和拓扑等分子描述符来表示化合物的结构特征。传统的抗生素磺胺西林和氨苄西林在模型开发中没有使用,因为它们的结构与所创建的化合物不同。生物活性数据首先被转化为pMIC值(即-log MIC),并用作QSAR调查的因变量。结果:具有高电子能和偶极矩的化合物是对金黄色葡萄球菌有效的抗菌药物,具有较低κ2值的吲哚衍生物是对MRSA标准菌株有效的抗菌药物,具有较低R值和较高2χv值的化合物是对MRSA分离株有效的抗菌药物。结论:化合物12和2分别对青霉素结合蛋白2和青霉素结合蛋白2a具有较好的结合评分。
{"title":"<i>In Silico</i> Studies of Indole Derivatives as Antibacterial Agents.","authors":"Mridul Shah,&nbsp;Adarsh Kumar,&nbsp;Ankit Kumar Singh,&nbsp;Harshwardhan Singh,&nbsp;Balasubramanian Narasimhan,&nbsp;Pradeep Kumar","doi":"10.3831/KPI.2023.26.2.147","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.147","url":null,"abstract":"<p><strong>Objectives: </strong>Molecular docking and QSAR studies of indole derivatives as antibacterial agents.</p><p><strong>Methods: </strong>In this study, we used a multiple linear regressions (MLR) approach to construct a 2D quantitative structure activity relationship of 14 reported indole derivatives. It was performed on the reported antibacterial activity data of 14 compounds based on theoretical chemical descriptors to construct statistical models that link structural properties of indole derivatives to antibacterial activity. We have also performed molecular docking studies of same compounds by using Maestro module of Schrodinger. A set the molecular descriptors like hydrophobic, geometric, electronic and topological characters were calculated to represent the structural features of compounds. The conventional antibiotics sultamicillin and ampicillin were not used in the model development since their structures are different from those of the created compounds. Biological activity data was first translated into pMIC values (i.e. -log MIC) and used as a dependent variable in QSAR investigation.</p><p><strong>Results: </strong>Compounds with high electronic energy and dipole moment were effective antibacterial agents against <i>S. aureus</i>, indole derivatives with lower κ<sub>2</sub> values were excellent antibacterial agents against MRSA standard strain, and compounds with lower R value and a high <sup>2</sup>χ<sup>v</sup> value were effective antibacterial agents against MRSA isolate.</p><p><strong>Conclusion: </strong>Compounds 12 and 2 showed better binding score against penicillin binding protein 2 and penicillin binding protein 2a respectively.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"147-157"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/12/jop-26-2-147.PMC10315882.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Treatment of Pyritum for Musculoskeletal Trauma: a protocol for systematic review. 肌骨骼创伤的外部治疗:一项系统评价方案。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.192
Ji Hye Hwang, Su Hyun Choi

Objectives: Musculoskeletal trauma is a common type of injury that can result from damage to the muscular or skeletal system and has been recognized as a leading cause of death and disability worldwide. This study aims to analyze the efficacy of Pyritum external treatment for musculoskeletal trauma.

Methods: Randomized controlled trials evaluating the external treatment effect of Pyritum on various types of musculoskeletal traumatic injuries will be considered and identified in the searches of eight databases from their inception to Feb 2023. There will be no restrictions with respect to the publication status, language, or country. The experimental intervention group will be treated with external application of Pyritum alone or in combination with other therapies, and the comparator intervention group will include all types of control interventions. The primary outcome will be measured as treatment efficacy rate, and secondary outcomes will include pain reduction, pain disappearance time, swelling, joint function, and recovery period. Assessment of the methodological quality of this study will be concluded using the risk of bias assessment recommended by the Cochrane Collaboration. If there are sufficient numbers of studies per group in terms of specific rating scales to compare the treatment effects of Pyrium alone and combined external treatment groups, we will consider subgroup analysis.

Results: This systematic review will be conducted in compliance with the PRISMA-P statement.

Conclusion: We will conduct an extensive search on the proposed topic within the available literature and provide systematic evidence for the efficacy and safety of external application of Pyritum for all types of musculoskeletal trauma. The evidence generated will help design interventions for the external use of Pyritum for this patient group.

目的:肌肉骨骼创伤是一种常见的损伤类型,可引起肌肉或骨骼系统的损伤,已被认为是世界范围内死亡和残疾的主要原因。本研究旨在分析吡嗪外敷治疗骨骼肌损伤的疗效。方法:通过对8个数据库从建立到2023年2月的检索,考虑并确定评估吡喃对不同类型肌肉骨骼创伤性损伤的外治疗效果的随机对照试验。没有关于出版状态、语言或国家的限制。实验干预组采用单独或联合其他疗法外涂Pyritum治疗,比较干预组包括所有类型的对照干预。主要结局以治疗有效率衡量,次要结局包括疼痛减轻、疼痛消失时间、肿胀、关节功能和恢复期。本研究方法学质量的评估将采用Cochrane Collaboration推荐的偏倚风险评估来完成。如果每组有足够数量的研究来比较单独使用Pyrium和联合外部治疗组的治疗效果,我们将考虑亚组分析。结果:本系统评价将按照PRISMA-P声明进行。结论:我们将在现有文献中对所提出的主题进行广泛的搜索,并为Pyritum外用治疗所有类型肌肉骨骼创伤的有效性和安全性提供系统的证据。所产生的证据将有助于为该患者组设计外部使用Pyritum的干预措施。
{"title":"External Treatment of Pyritum for Musculoskeletal Trauma: a protocol for systematic review.","authors":"Ji Hye Hwang,&nbsp;Su Hyun Choi","doi":"10.3831/KPI.2023.26.2.192","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.192","url":null,"abstract":"<p><strong>Objectives: </strong>Musculoskeletal trauma is a common type of injury that can result from damage to the muscular or skeletal system and has been recognized as a leading cause of death and disability worldwide. This study aims to analyze the efficacy of Pyritum external treatment for musculoskeletal trauma.</p><p><strong>Methods: </strong>Randomized controlled trials evaluating the external treatment effect of Pyritum on various types of musculoskeletal traumatic injuries will be considered and identified in the searches of eight databases from their inception to Feb 2023. There will be no restrictions with respect to the publication status, language, or country. The experimental intervention group will be treated with external application of Pyritum alone or in combination with other therapies, and the comparator intervention group will include all types of control interventions. The primary outcome will be measured as treatment efficacy rate, and secondary outcomes will include pain reduction, pain disappearance time, swelling, joint function, and recovery period. Assessment of the methodological quality of this study will be concluded using the risk of bias assessment recommended by the Cochrane Collaboration. If there are sufficient numbers of studies per group in terms of specific rating scales to compare the treatment effects of Pyrium alone and combined external treatment groups, we will consider subgroup analysis.</p><p><strong>Results: </strong>This systematic review will be conducted in compliance with the PRISMA-P statement.</p><p><strong>Conclusion: </strong>We will conduct an extensive search on the proposed topic within the available literature and provide systematic evidence for the efficacy and safety of external application of Pyritum for all types of musculoskeletal trauma. The evidence generated will help design interventions for the external use of Pyritum for this patient group.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"192-197"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/a2/jop-26-2-192.PMC10315878.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9793260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by Withania somnifera in an Experimental Model of Allergic Asthma in Rats. 益母草对变应性哮喘大鼠气道重构的免疫、生化和组织病理学改变的调节作用。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.158
Nafaa Hasan Ali, Sana Rehman, Maaz Naqvi, Kavita Gulati, Arunabha Ray

Objectives: Airway remodeling in asthma involves chronic inflammation associated with structural changes, which result in severe airflow limitation and very few therapeutic options. Thus, the present study was designed to experimentally evaluate the ameliorative effects of Withania somnifera (WS) root extract against Ovalbumin (OVA)-induced airway remodeling in a rat model of asthma.

Methods: Wistar rats were immunized (i.p) and challenged (aerosol) with ovalbumin (OVA), and the effects of WS extract were investigated on the development and progress of airway remodeling by assessing immunological, biochemical, and histological changes in these rats.

Results: OVA-immunization and challenge in rats resulted in significant increases in the levels of IL-13, 8-OhdG, TGF-β, hydroxyproline, and periostin in bronchoalveolar lavage fluid (BALF) and serum/lung homogenate compared to normal control (saline only) rats, and these changes were attenuated after WS extract (200 and 400 mg/kg), as well as dexamethasone (DEX, 1 mg/kg) pretreatments. Further, WS extract attenuated histopathological changes and maintained lung integrity. In herb-drug interactions, sub-threshold doses of WS extract and DEX showed synergistic effects on all parameters studied as compared to either form of monotherapy.

Conclusion: These results indicated that WS exerted significant protective effects against airway remodeling in the experimental model by modulating inflammatory and fibrotic cytokines, and could have the potential for developing a therapeutic alternative/adjunct for the treatment of airway remodeling of bronchial asthma.

目的:哮喘气道重塑涉及与结构改变相关的慢性炎症,导致严重的气流限制和很少的治疗选择。因此,本研究旨在通过实验评估Withania somnifera (WS)根提取物对卵清蛋白(OVA)诱导的哮喘大鼠气道重构的改善作用。方法:采用卵清蛋白(OVA)免疫(i.p)和雾化(aerosol)刺激Wistar大鼠,通过观察其免疫、生化和组织学变化,研究WS提取物对气道重塑发生和进展的影响。结果:ova免疫和刺激导致大鼠支气管肺泡灌洗液(BALF)和血清/肺匀浆中IL-13、8-OhdG、TGF-β、羟脯氨酸和骨膜素水平显著高于正常对照组(仅含生理盐水),WS提取物(200和400 mg/kg)和地塞米松(DEX, 1 mg/kg)预处理后这些变化减弱。此外,WS提取物可减轻组织病理变化,维持肺的完整性。在草药-药物相互作用中,与单一疗法相比,亚阈值剂量的WS提取物和DEX在所有研究参数上都显示出协同效应。结论:WS通过调节炎症和纤维化细胞因子对实验模型气道重构具有显著的保护作用,可能成为支气管哮喘气道重构治疗的替代疗法/辅助疗法。
{"title":"Modulation of Immunological, Biochemical, and Histopathological Changes of Airway Remodeling by <i>Withania somnifera</i> in an Experimental Model of Allergic Asthma in Rats.","authors":"Nafaa Hasan Ali,&nbsp;Sana Rehman,&nbsp;Maaz Naqvi,&nbsp;Kavita Gulati,&nbsp;Arunabha Ray","doi":"10.3831/KPI.2023.26.2.158","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.158","url":null,"abstract":"<p><strong>Objectives: </strong>Airway remodeling in asthma involves chronic inflammation associated with structural changes, which result in severe airflow limitation and very few therapeutic options. Thus, the present study was designed to experimentally evaluate the ameliorative effects of <i>Withania somnifera</i> (WS) root extract against Ovalbumin (OVA)-induced airway remodeling in a rat model of asthma.</p><p><strong>Methods: </strong>Wistar rats were immunized (i.p) and challenged (aerosol) with ovalbumin (OVA), and the effects of WS extract were investigated on the development and progress of airway remodeling by assessing immunological, biochemical, and histological changes in these rats.</p><p><strong>Results: </strong>OVA-immunization and challenge in rats resulted in significant increases in the levels of IL-13, 8-OhdG, TGF-β, hydroxyproline, and periostin in bronchoalveolar lavage fluid (BALF) and serum/lung homogenate compared to normal control (saline only) rats, and these changes were attenuated after WS extract (200 and 400 mg/kg), as well as dexamethasone (DEX, 1 mg/kg) pretreatments. Further, WS extract attenuated histopathological changes and maintained lung integrity. In herb-drug interactions, sub-threshold doses of WS extract and DEX showed synergistic effects on all parameters studied as compared to either form of monotherapy.</p><p><strong>Conclusion: </strong>These results indicated that WS exerted significant protective effects against airway remodeling in the experimental model by modulating inflammatory and fibrotic cytokines, and could have the potential for developing a therapeutic alternative/adjunct for the treatment of airway remodeling of bronchial asthma.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"158-166"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/23/jop-26-2-158.PMC10315884.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9793267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro Antibacterial Activity and Wound Healing Effects of Achillea millefolium Essential Oil in Rat. 千叶阿喀琉叶精油对大鼠体外抗菌活性及伤口愈合作用的研究。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.167
Mohammad Reza Ghasemi, Akram Ranjbar, Pari Tamri, Shabnam Pourmoslemi, Alireza Nourian, Dara Dastan

Objectives: In this study we aimed to evaluate the in vitro antibacterial activity and wound healing properties of Achillea millefolium essential oil (AMEO) in full-thickness wound model in rat. The antibacterial activity of AMEO was evaluated against Staphylococcus aureus and Pseudomonas aeruginosa using the broth dilution method.

Methods: The 2 cm × 2 cm full-thickness excisional wounds were created on the back of animals. Topical therapy was applied twice a day using 1%, 2%, and 3% w/w AMEO ointments, and the measurement of the wounds area was carried out every 3 days, after that the wound closure percentage was calculated in these days. Hydroxyproline content and histopathological evaluation of wound tissue samples were carried out on day 7 and 14 post wounding. Eucerin was used for the treatment of vehicle control group and negative control group received no treatment.

Results: Our results revealed the bacteriostatic activity of AMEO against S. aureus and P. aeruginosa. Wound healing activity evaluation of AMEO showed the significant increase (p < 0.05) in the wound closure percentages in rats treated with AMEO 1% and 2% comparing to those of non-treatment group. In addition, hydroxyproline contents of tissue significantly (p < 0.01) increased in AMEO 1% and 2% comparing to non-treatment group. Histopathological evaluations of wound tissue samples on day 7 and 14 demonstrated higher accumulation of collagen fibers, reduction of edema and inflammation and also formation of tissue appendages in 1% and 2% AMEO treated groups in comparison with non-treatment group.

Conclusion: The results of this study indicated that AMEO has the potential to be used as a safe and effective wound healing agent.

目的:研究阿喀琉叶精油(AMEO)在大鼠全层创面模型中的体外抗菌活性和创面愈合性能。采用肉汤稀释法测定AMEO对金黄色葡萄球菌和铜绿假单胞菌的抑菌活性。方法:在动物背部造2 cm × 2 cm全层切除创面。采用1%、2%、3% w/w的AMEO软膏进行局部治疗,每日2次,每3天测量创面面积,计算创面愈合率。分别于伤后第7天和第14天对伤口组织样品进行羟脯氨酸含量和组织病理学评价。阴性对照组不进行治疗,对照组采用优素林治疗。结果:AMEO对金黄色葡萄球菌和铜绿假单胞菌具有抑菌活性。伤口愈合活性评价显示,与未治疗组相比,治疗组伤口愈合率分别提高1%和2%,差异有统计学意义(p < 0.05)。此外,与未处理组相比,AMEO组组织中羟脯氨酸含量显著提高1%和2% (p < 0.01)。第7天和第14天的组织病理学评估显示,与未治疗组相比,1%和2% AMEO治疗组胶原纤维的积累更多,水肿和炎症减少,组织附件的形成。结论:本研究结果表明,AMEO具有作为一种安全有效的伤口愈合剂的潜力。
{"title":"<i>In vitro</i> Antibacterial Activity and Wound Healing Effects of <i>Achillea millefolium</i> Essential Oil in Rat.","authors":"Mohammad Reza Ghasemi,&nbsp;Akram Ranjbar,&nbsp;Pari Tamri,&nbsp;Shabnam Pourmoslemi,&nbsp;Alireza Nourian,&nbsp;Dara Dastan","doi":"10.3831/KPI.2023.26.2.167","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.167","url":null,"abstract":"<p><strong>Objectives: </strong>In this study we aimed to evaluate the <i>in vitro</i> antibacterial activity and wound healing properties of <i>Achillea millefolium</i> essential oil (AMEO) in full-thickness wound model in rat. The antibacterial activity of AMEO was evaluated against <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> using the broth dilution method.</p><p><strong>Methods: </strong>The 2 cm × 2 cm full-thickness excisional wounds were created on the back of animals. Topical therapy was applied twice a day using 1%, 2%, and 3% w/w AMEO ointments, and the measurement of the wounds area was carried out every 3 days, after that the wound closure percentage was calculated in these days. Hydroxyproline content and histopathological evaluation of wound tissue samples were carried out on day 7 and 14 post wounding. Eucerin was used for the treatment of vehicle control group and negative control group received no treatment.</p><p><strong>Results: </strong>Our results revealed the bacteriostatic activity of AMEO against <i>S. aureus</i> and <i>P. aeruginosa</i>. Wound healing activity evaluation of AMEO showed the significant increase (p < 0.05) in the wound closure percentages in rats treated with AMEO 1% and 2% comparing to those of non-treatment group. In addition, hydroxyproline contents of tissue significantly (p < 0.01) increased in AMEO 1% and 2% comparing to non-treatment group. Histopathological evaluations of wound tissue samples on day 7 and 14 demonstrated higher accumulation of collagen fibers, reduction of edema and inflammation and also formation of tissue appendages in 1% and 2% AMEO treated groups in comparison with non-treatment group.</p><p><strong>Conclusion: </strong>The results of this study indicated that AMEO has the potential to be used as a safe and effective wound healing agent.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"167-174"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/a2/jop-26-2-167.PMC10315885.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antibacterial and Anti-Glucosyltransferase Activity of Verbascum speciosum Against Cariogenic Streptococci. 马齿苋对龋齿链球菌的抗菌及抗糖基转移酶活性研究。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.139
Shabnam Pourmoslemi, Amir Larki-Harchegani, Sajad Daneshyar, Dara Dastan, Amir Nili-Ahmadabadi, Mina Jazaeri

Objectives: Dental caries is a prevalent chronic human infection worldwide and several plants have shown anticariogenic properties through antibacterial activity against oral pathogens. The present study aimed to assess anticariogenic activity of Verbascum speciosum, in search of novel agents for the prevention and treatment of dental caries.

Methods: Hydro-alcoholic extracts from flowers and total aerial parts of the plant were prepared by maceration. Antibacterial activity of the extracts against Streptococcus mutans (ATCC 35668) and Streptococcus sobrinus (ATCC 27607) was investigated by agar diffusion and microdilution techniques. Inhibitory concentration-fifty values of the flowers' extract against Streptococcus mutans glucosyltransferase enzymes were determined. The total flavonoid content of the extracts was determined using an aluminum chloride reaction.

Results: Verbascum speciosum flowers' extract showed significantly higher flavonoid content and antibacterial activity; with minimum inhibitory concentrations of 100 and 200 µg/mL for Streptococcus mutans and Streptococcus sobrinus, respectively. The extract inhibited the synthesis of glucan by cell-associated and extracellular glucosyltransferase enzymes in a dose-dependent manner with higher activity against the extracellular enzyme.

Conclusion: This study indicated effective anticariogenic activity of Verbascum speciosum flowers extract. This extract can be considered as an alternative to current anticaries therapies or an additive to dental care products.

目的:龋齿是世界范围内常见的人类慢性感染,一些植物通过对口腔病原菌的抗菌作用显示出抗龋齿的特性。本研究旨在探讨棘草的抑癌活性,以期寻找预防和治疗龋齿的新药物。方法:采用浸渍法制备花和地上部分水醇提取物。采用琼脂扩散法和微量稀释法研究其对变形链球菌(ATCC 35668)和sobrinus链球菌(ATCC 27607)的抑菌活性。测定了花提取物对变形链球菌葡萄糖基转移酶的抑制浓度- 50值。采用氯化铝反应法测定提取物的总黄酮含量。结果:马齿苋花提取物具有较高的类黄酮含量和抗菌活性;对变形链球菌和红链球菌的最低抑菌浓度分别为100和200µg/mL。该提取物以剂量依赖的方式抑制细胞相关和细胞外葡萄糖基转移酶合成葡聚糖,对细胞外酶具有较高的活性。结论:本研究表明虎鞭草花提取物具有良好的抗肿瘤活性。这种提取物可以被认为是当前抗肿瘤疗法的替代品或牙科保健产品的添加剂。
{"title":"Antibacterial and Anti-Glucosyltransferase Activity of <i>Verbascum speciosum</i> Against Cariogenic Streptococci.","authors":"Shabnam Pourmoslemi,&nbsp;Amir Larki-Harchegani,&nbsp;Sajad Daneshyar,&nbsp;Dara Dastan,&nbsp;Amir Nili-Ahmadabadi,&nbsp;Mina Jazaeri","doi":"10.3831/KPI.2023.26.2.139","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.139","url":null,"abstract":"<p><strong>Objectives: </strong>Dental caries is a prevalent chronic human infection worldwide and several plants have shown anticariogenic properties through antibacterial activity against oral pathogens. The present study aimed to assess anticariogenic activity of <i>Verbascum speciosum</i>, in search of novel agents for the prevention and treatment of dental caries.</p><p><strong>Methods: </strong>Hydro-alcoholic extracts from flowers and total aerial parts of the plant were prepared by maceration. Antibacterial activity of the extracts against <i>Streptococcus mutans</i> (ATCC 35668) and <i>Streptococcus sobrinus</i> (ATCC 27607) was investigated by agar diffusion and microdilution techniques. Inhibitory concentration-fifty values of the flowers' extract against <i>Streptococcus mutans</i> glucosyltransferase enzymes were determined. The total flavonoid content of the extracts was determined using an aluminum chloride reaction.</p><p><strong>Results: </strong><i>Verbascum speciosum</i> flowers' extract showed significantly higher flavonoid content and antibacterial activity; with minimum inhibitory concentrations of 100 and 200 µg/mL for <i>Streptococcus mutans</i> and <i>Streptococcus sobrinus</i>, respectively. The extract inhibited the synthesis of glucan by cell-associated and extracellular glucosyltransferase enzymes in a dose-dependent manner with higher activity against the extracellular enzyme.</p><p><strong>Conclusion: </strong>This study indicated effective anticariogenic activity of Verbascum speciosum flowers extract. This extract can be considered as an alternative to current anticaries therapies or an additive to dental care products.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"139-146"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/92/jop-26-2-139.PMC10315880.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Satisfaction and Perceived Effectiveness on Herbal Decoctions for Postpartum Care: a cross-sectional survey of mother's experience. 产后护理中草药汤剂的满意度和感知效果:一项母亲经验的横断面调查。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.175
Min Kyung Hyun, Jang Kyung Park, Sung Yoon Oh

Objectives: In East Asia, postpartum care has traditionally been considered important for maternal health; however, studies on this are still insufficient. Therefore, we examined the satisfaction and perceived effectiveness of herbal decoctions used in postpartum care in a city in the Republic of Korea (ROK).

Methods: We analyzed anonymized secondary data obtained from a retrospective cross-sectional survey of women who had taken herbal decoctions provided by the support service for women giving birth in a local city in ROK. The questionnaire items consisted of basic information regarding childbirth, the need for the herbal decoction support service, satisfaction, and the effectiveness of the service received.

Results: A total of 68 women were included in the study, and those aged 30-39 accounted for 73.13%. Of the 68 women, 79.37% visited within 3 weeks of childbirth. Women's satisfaction regarding herbal decoction support for postpartum care was 76.47%, and most women (98.53%) responded that they needed it more than twice. More than 50% of women showed improvement in puerperal wind disorders, weight gain, and delayed eliminated lochia.

Conclusion: A large proportion of women who took herbal decoctions reported satisfaction and perceived effectiveness when used to treat puerperal wind disorders. Nevertheless, future well-designed clinical studies are needed to provide information on whether herbal decoctions effectively prevent and treat puerperal wind disorders.

目标:在东亚,产后护理传统上被认为对产妇保健很重要;然而,这方面的研究仍然不足。因此,我们调查了在韩国(韩国)一个城市的产后护理中使用草药煎剂的满意度和感知有效性。方法:我们对韩国某地方城市妇女分娩支持服务提供的草药煎剂的妇女进行回顾性横断面调查,并对匿名的二次数据进行分析。问卷内容包括分娩基本情况、对中药汤剂支持服务的需求、满意度和服务效果。结果:共纳入68名女性,年龄30-39岁占73.13%。在68名妇女中,79.37%在分娩后3周内就诊。女性对产后护理中草药汤剂支持的满意度为76.47%,大多数女性(98.53%)回答需要两次以上。超过50%的妇女表现出产褥期风障碍、体重增加和延迟消除恶露的改善。结论:服用中药煎剂治疗产褥期风病的妇女中,有相当大比例的妇女对中药煎剂的疗效满意。然而,未来需要精心设计的临床研究来提供草药煎剂是否有效预防和治疗产褥期风病的信息。
{"title":"Satisfaction and Perceived Effectiveness on Herbal Decoctions for Postpartum Care: a cross-sectional survey of mother's experience.","authors":"Min Kyung Hyun,&nbsp;Jang Kyung Park,&nbsp;Sung Yoon Oh","doi":"10.3831/KPI.2023.26.2.175","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.175","url":null,"abstract":"<p><strong>Objectives: </strong>In East Asia, postpartum care has traditionally been considered important for maternal health; however, studies on this are still insufficient. Therefore, we examined the satisfaction and perceived effectiveness of herbal decoctions used in postpartum care in a city in the Republic of Korea (ROK).</p><p><strong>Methods: </strong>We analyzed anonymized secondary data obtained from a retrospective cross-sectional survey of women who had taken herbal decoctions provided by the support service for women giving birth in a local city in ROK. The questionnaire items consisted of basic information regarding childbirth, the need for the herbal decoction support service, satisfaction, and the effectiveness of the service received.</p><p><strong>Results: </strong>A total of 68 women were included in the study, and those aged 30-39 accounted for 73.13%. Of the 68 women, 79.37% visited within 3 weeks of childbirth. Women's satisfaction regarding herbal decoction support for postpartum care was 76.47%, and most women (98.53%) responded that they needed it more than twice. More than 50% of women showed improvement in puerperal wind disorders, weight gain, and delayed eliminated lochia.</p><p><strong>Conclusion: </strong>A large proportion of women who took herbal decoctions reported satisfaction and perceived effectiveness when used to treat puerperal wind disorders. Nevertheless, future well-designed clinical studies are needed to provide information on whether herbal decoctions effectively prevent and treat puerperal wind disorders.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"175-183"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/6f/jop-26-2-175.PMC10315879.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials. 中药对哮喘患者肺功能的疗效:随机对照试验的系统回顾和荟萃分析。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.124
Alireza Derakhshan, Masoumeh Sadeghi, Amir-Mohammad-Hashem Asnaashari, Mohsen Dehghani, Roshanak Salari, Majid Khadem-Rezaiyan, Majid Mirsadraee, Shahin Saeidinejat, Shima Jalali, Shabnam Jalali

Objectives: The present study was designed to conduct a comprehensive systematic review and meta-analysis to assess the efficacy of herbal medicines as add-on therapy on lung function in asthmatic patients.

Methods: A comprehensive search of online databases was performed up to December 2021 to identify randomized controlled trials that used orally herbal preparations for asthma as add-on therapy. Studies were assessed for methodological quality using the Cochrane Collaboration's Risk of Bias tool. The main outcome was percent predicted value of forced expiratory volume (% predicted FEV1). Pooled weighted mean difference (WMD) estimate with corresponding 95% confidence interval (CI) was calculated using inverse-variance weights method while random effects meta-analysis was used, taking into account clinical and conceptual heterogeneity.

Results: As a result, 1,525 studies were identified. 169 studies were reviewed in-depth and 23 studies met our systematic review inclusion criteria. Finally, nine randomized controlled trials were included in the meta-analysis. Findings indicated that use of herbal medicines in patients with asthma significantly improved % predicted FEV1 (WMD 3.73, 95% CI 1.76-5.70), with no evidence for significant heterogeneity (p = 0.56 [Q statistic], I2 = 0.0%). In subgroup analysis by age, improvement in % predicted FEV1 was higher and significant in adults (WMD 5.16; 95% CI 2.68-7.63) compared to children (WMD = 1.27; 95% CI -1.98-4.51). Sensitivity analysis showed the significant effect of herbal medicine consumption on improving FEV1 was consistently (range of summary WMDs 3.27-4.59), indicating that the meta-analysis model was robust. There was no evidence of publication bias both visually and statistically.

Conclusion: Findings support, the complementary use of herbal medicines resulted in significant improvement in the lung function compared to standard treatment in asthmatic patients with no considerable adverse events. This improvement is more likely to be observed amongst adults.

目的:本研究旨在进行一项全面的系统评价和荟萃分析,以评估草药作为辅助治疗对哮喘患者肺功能的疗效。方法:对截至2021年12月的在线数据库进行全面检索,以确定使用口服草药制剂作为哮喘附加治疗的随机对照试验。使用Cochrane协作的偏倚风险工具评估研究的方法学质量。主要终点为用力呼气量预测值百分比(预测FEV1百分比)。考虑到临床和概念上的异质性,采用反方差权重法计算具有相应95%置信区间(CI)的合并加权平均差(WMD)估计值,同时采用随机效应荟萃分析。结果:1525项研究被确认。169项研究被深入审查,23项研究符合我们的系统审查纳入标准。最后,meta分析纳入了9个随机对照试验。结果显示,哮喘患者使用中草药可显著改善预测FEV1的% (WMD 3.73, 95% CI 1.76 ~ 5.70),无显著异质性(p = 0.56 [Q统计值],I2 = 0.0%)。在按年龄分组的亚组分析中,成人预测FEV1的改善率更高且显著(WMD为5.16;95% CI 2.68-7.63)与儿童相比(WMD = 1.27;95% ci -1.98-4.51)。敏感性分析显示,草药消费对改善FEV1的显著作用是一致的(总wmd范围为3.27-4.59),表明meta分析模型是稳健的。在视觉上和统计上都没有发表偏倚的证据。结论:研究结果支持,与标准治疗相比,补充使用草药可显著改善哮喘患者的肺功能,无明显不良事件。这种改善在成年人中更容易观察到。
{"title":"Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials.","authors":"Alireza Derakhshan,&nbsp;Masoumeh Sadeghi,&nbsp;Amir-Mohammad-Hashem Asnaashari,&nbsp;Mohsen Dehghani,&nbsp;Roshanak Salari,&nbsp;Majid Khadem-Rezaiyan,&nbsp;Majid Mirsadraee,&nbsp;Shahin Saeidinejat,&nbsp;Shima Jalali,&nbsp;Shabnam Jalali","doi":"10.3831/KPI.2023.26.2.124","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.124","url":null,"abstract":"<p><strong>Objectives: </strong>The present study was designed to conduct a comprehensive systematic review and meta-analysis to assess the efficacy of herbal medicines as add-on therapy on lung function in asthmatic patients.</p><p><strong>Methods: </strong>A comprehensive search of online databases was performed up to December 2021 to identify randomized controlled trials that used orally herbal preparations for asthma as add-on therapy. Studies were assessed for methodological quality using the Cochrane Collaboration's Risk of Bias tool. The main outcome was percent predicted value of forced expiratory volume (% predicted FEV1). Pooled weighted mean difference (WMD) estimate with corresponding 95% confidence interval (CI) was calculated using inverse-variance weights method while random effects meta-analysis was used, taking into account clinical and conceptual heterogeneity.</p><p><strong>Results: </strong>As a result, 1,525 studies were identified. 169 studies were reviewed in-depth and 23 studies met our systematic review inclusion criteria. Finally, nine randomized controlled trials were included in the meta-analysis. Findings indicated that use of herbal medicines in patients with asthma significantly improved % predicted FEV1 (WMD 3.73, 95% CI 1.76-5.70), with no evidence for significant heterogeneity (p = 0.56 [Q statistic], I<sup>2</sup> = 0.0%). In subgroup analysis by age, improvement in % predicted FEV1 was higher and significant in adults (WMD 5.16; 95% CI 2.68-7.63) compared to children (WMD = 1.27; 95% CI -1.98-4.51). Sensitivity analysis showed the significant effect of herbal medicine consumption on improving FEV1 was consistently (range of summary WMDs 3.27-4.59), indicating that the meta-analysis model was robust. There was no evidence of publication bias both visually and statistically.</p><p><strong>Conclusion: </strong>Findings support, the complementary use of herbal medicines resulted in significant improvement in the lung function compared to standard treatment in asthmatic patients with no considerable adverse events. This improvement is more likely to be observed amongst adults.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"124-138"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/a8/jop-26-2-124.PMC10315876.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome. 针刺治疗人多囊卵巢/卵巢综合征疗效研究进展
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.105
Natália M de Oliveira, Jorge Machado, Lara Lopes, Maria Begoña Criado

Objectives: Human Polycystic Ovary/Ovarian Syndrome (PCOS), a frequent endocrine pathophysiology among women of fertile age, is associated with woman's lifespan endocrine, metabolic and psychological implications. Long-term usage side effects of allopathic strategies and their low efficacy made complementary medicine treatments a relevant subject for these patients. The main aim of this work is to review the efficiency of the acupuncture treatment reported in the latest studies on literature regarding PCOS patients.

Methods: A comprehensive literature search, in English language, about the use of acupuncture on the management of PCOS, was conducted in October 2020 using EBSCO, Cochrane, PubMed, Medline, Embase, databases for randomised and non-randomised controlled trials between 2015 and 2020 (09/2015-10/2020), following the PRISMA protocol.

Results: This research led us to an analysis, according to PICOS, of six final papers selected among 178 in total. The articles addressed distinct aspects of the PCOS condition, diverse acupuncture techniques and different main and secondary outcomes in agreement to the respective main objective. According to this review, acupuncture seems to be useful for the treatment of this debilitating and chronic health condition which affects millions of women worldwide, many of them part of the workforce in their community.

Conclusion: Despite of the display of these positive results addressing acupuncture treatments to manage PCOS major symptoms - whether they are reproductive, metabolic, or mental health features - more research is urgent. Randomized, double blinded controlled trials with improved quality design and following STRICTA and/or CONSORT recommendations are necessary to engage acupuncture as a standardized and scientific validated technique in PCOS condition.

目的:人类多囊卵巢/卵巢综合征(PCOS)是育龄妇女中一种常见的内分泌病理生理,与女性一生的内分泌、代谢和心理相关。长期使用对抗疗法的副作用和低疗效使得补充药物治疗成为这些患者的相关课题。本文旨在对近年来文献报道的针灸治疗多囊卵巢综合征的疗效进行综述。方法:根据PRISMA协议,于2020年10月使用EBSCO、Cochrane、PubMed、Medline、Embase以及2015年至2020年(2015年9月至2020年10月)的随机和非随机对照试验数据库,对针灸在PCOS治疗中的应用进行全面的英文文献检索。结果:根据PICOS,我们从总共178篇论文中选择了6篇最终论文进行了分析。文章讨论了多囊卵巢综合征的不同方面,不同的针灸技术和不同的主要和次要结果,以符合各自的主要目标。根据这篇综述,针灸似乎对治疗这种使人衰弱的慢性健康状况有用,这种疾病影响着全世界数百万妇女,其中许多人是社区劳动力的一部分。结论:尽管针灸治疗在治疗多囊卵巢综合征主要症状(无论是生殖、代谢还是心理健康特征)方面显示了这些积极的结果,但仍需要更多的研究。改进质量设计并遵循STRICTA和/或CONSORT建议的随机、双盲对照试验是必要的,以使针灸成为PCOS条件下标准化和科学验证的技术。
{"title":"A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome.","authors":"Natália M de Oliveira,&nbsp;Jorge Machado,&nbsp;Lara Lopes,&nbsp;Maria Begoña Criado","doi":"10.3831/KPI.2023.26.2.105","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.105","url":null,"abstract":"<p><strong>Objectives: </strong>Human Polycystic Ovary/Ovarian Syndrome (PCOS), a frequent endocrine pathophysiology among women of fertile age, is associated with woman's lifespan endocrine, metabolic and psychological implications. Long-term usage side effects of allopathic strategies and their low efficacy made complementary medicine treatments a relevant subject for these patients. The main aim of this work is to review the efficiency of the acupuncture treatment reported in the latest studies on literature regarding PCOS patients.</p><p><strong>Methods: </strong>A comprehensive literature search, in English language, about the use of acupuncture on the management of PCOS, was conducted in October 2020 using EBSCO, Cochrane, PubMed, Medline, Embase, databases for randomised and non-randomised controlled trials between 2015 and 2020 (09/2015-10/2020), following the PRISMA protocol.</p><p><strong>Results: </strong>This research led us to an analysis, according to PICOS, of six final papers selected among 178 in total. The articles addressed distinct aspects of the PCOS condition, diverse acupuncture techniques and different main and secondary outcomes in agreement to the respective main objective. According to this review, acupuncture seems to be useful for the treatment of this debilitating and chronic health condition which affects millions of women worldwide, many of them part of the workforce in their community.</p><p><strong>Conclusion: </strong>Despite of the display of these positive results addressing acupuncture treatments to manage PCOS major symptoms - whether they are reproductive, metabolic, or mental health features - more research is urgent. Randomized, double blinded controlled trials with improved quality design and following STRICTA and/or CONSORT recommendations are necessary to engage acupuncture as a standardized and scientific validated technique in PCOS condition.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"105-123"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/c7/jop-26-2-105.PMC10315877.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Protective Effect of Citral, Silymarin, and Thymoquinone on Methotrexate-Induced Lung Injury in Rats. 柠檬醛、水飞蓟素和百里醌对甲氨蝶呤所致大鼠肺损伤的保护作用。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.184
Amani Sakineh, Mohammad Foad Noorbakhsh, Nasrollah Ahmadi, Nazifi Saeed, Barzan Behdokht

Objectives: Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity.

Methods: Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO2. Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation.

Results: In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group.

Conclusion: Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.

目的:一些研究报道甲氨蝶呤是一种导致肺损伤的抗癌和免疫抑制药物。因此,本研究旨在探讨水飞蓟素、柠檬醛和百里醌对甲氨蝶呤所致肺毒性的保护作用。方法:48只大鼠分为健康组、甲氨蝶呤组、药物载体对照组和水飞蓟素、柠檬醛、百里醌治疗组。实验结束后,用CO2麻醉处死大鼠。分离肺组织样品,测定其抗氧化活性和组织病理学评价。结果:百里醌治疗组与甲氨蝶呤组相比,总抗氧化能力和丙二醛浓度分别显著升高和降低。甲氨蝶呤组肺组织病理学检查显示出血充血,血管周围单核炎性淋巴细胞结节样积聚,血管周围少量中性粒细胞,小血管周围有炎性细胞。而治疗组,尤其是百里醌治疗组未见明显病理改变。结论:百里醌对甲氨蝶呤所致肺损伤的保护作用最大,可能与其抗氧化作用有关。
{"title":"Evaluation of the Protective Effect of Citral, Silymarin, and Thymoquinone on Methotrexate-Induced Lung Injury in Rats.","authors":"Amani Sakineh,&nbsp;Mohammad Foad Noorbakhsh,&nbsp;Nasrollah Ahmadi,&nbsp;Nazifi Saeed,&nbsp;Barzan Behdokht","doi":"10.3831/KPI.2023.26.2.184","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.184","url":null,"abstract":"<p><strong>Objectives: </strong>Several studies have reported that methotrexate is an anti-cancer and immunosuppressive drug leading to lung injury. Therefore, the present study aimed to investigate the protective effects of silymarin, citral, and thymoquinone on methotrexate-induced pulmonary toxicity.</p><p><strong>Methods: </strong>Forty-eight rats were divided into six groups, including healthy, Methotrexate, and drug carrier control groups and silymarin, citral, and thymoquinone treatment groups. At the end of the experiment, the studied rats were anesthetized and sacrificed by CO<sub>2</sub>. Lung tissue samples were isolated to measure the antioxidant activity and histopathological evaluation.</p><p><strong>Results: </strong>In the thymoquinone treatment group, the concentration of total antioxidant capacity and Malondialdehyde increased and decreased significantly, respectively, compared to the methotrexate group. The histopathological evaluation of the lung of the methotrexate group showed hemorrhage and congestion, the nodule-like accumulation of mononuclear inflammatory lymphocytes around the blood vessel, a small number of neutrophils around the blood vessel, and the inflammatory cells around the small vessels. However, no significant pathological alterations were observed in the treatment groups, especially the thymoquinone treatment group.</p><p><strong>Conclusion: </strong>Thymoquinone has the greatest protective effect on methotrexate-induced lung injury, probably due to its antioxidant effect.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"184-191"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/d2/jop-26-2-184.PMC10315881.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9802264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Health Insurance Data Analysis for the Second-Wave Development of Korean Medicine Clinical Practice Guidelines in South Korea. 国民健康保险数据分析在韩国第二波发展的韩国医学临床实践指南。
IF 1.4 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-06-30 DOI: 10.3831/KPI.2023.26.2.198
Chan-Young Kwon, Seungwon Shin, O-Jin Kwon, Wonkyung Moon, Namkwen Kim, Minjung Park

Objectives: After the evidence-based Korean medicine clinical practice guidelines (KM-CPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea.

Methods: In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea.

Results: The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest.

Conclusion: This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.

▽目的:继2021年制定了针对30种目标疾病的循证韩国医学临床实践指南(KM-CPGs)之后,提出了针对34种疾病的第二次开发KM-CPGs。本研究旨在探讨韩国KM-CPGs第二波发展中候选疾病的发展重点。方法:在本研究中,我们分析了2017年至2018年健康保险审查和评估服务国家患者样本数据,以确定韩国现实世界临床环境中KM-CPGs第二波发展候选人的需求和经济重要性。结果:分析了年就诊人次和患者数、年人均医疗费用和单位医疗费用。肌肉骨骼疾病,包括坐骨神经痛和肩关节粘连性囊炎,是关于就诊人数和患者数量以及每家机构年度医疗保健支出的最重要主题。其中坐骨神经痛占就诊总次数的52.05%,占就诊总人数的48.34%,占医院总治疗费用的42.12%,比例极高。然而,脑瘫(占住院总人数的36.03%,占住院总人数的24.55%)是住院临床环境中比肌肉骨骼疾病或癌症更重要的话题,该话题的人均医疗保健支出排名最高。此外,骨折被发现是非常重要的住院病人的临床设置。没有患者有甲型流感病毒感染或创伤后应激障碍访问KM医疗机构感兴趣。结论:本研究突出了现实临床环境与研究领域在某些课题上的差距。本研究结果可为今后KM-CPGs的第二波发展提供指导。
{"title":"National Health Insurance Data Analysis for the Second-Wave Development of Korean Medicine Clinical Practice Guidelines in South Korea.","authors":"Chan-Young Kwon,&nbsp;Seungwon Shin,&nbsp;O-Jin Kwon,&nbsp;Wonkyung Moon,&nbsp;Namkwen Kim,&nbsp;Minjung Park","doi":"10.3831/KPI.2023.26.2.198","DOIUrl":"https://doi.org/10.3831/KPI.2023.26.2.198","url":null,"abstract":"<p><strong>Objectives: </strong>After the evidence-based Korean medicine clinical practice guidelines (KM-CPGs) for 30 targeted diseases were developed in 2021, 34 diseases have been proposed for the second-wave development of the KM-CPGs. The purpose of this study was to investigate the development priorities of the candidate diseases into the second-wave development of KM-CPGs in south Korea.</p><p><strong>Methods: </strong>In this study, we analyzed the Health Insurance Review and Assessment Service National Patient Sample data from 2017 to 2018 to determine the demand and economic importance of the candidates for the second-wave development of KM-CPGs in real-world clinical settings in Korea.</p><p><strong>Results: </strong>The annual number of visits and patients, annual healthcare expenditure per patient, and healthcare expenditure per institution were analyzed. Musculoskeletal disorders, including sciatica and adhesive capsulitis of the shoulder, were the most important topics regarding the number of visits and patients and annual healthcare expenditure per institution. Specifically, sciatica (52.05% of the total number of visits, 48.34% of the total number of patients, and 42.12% of the total treatment expenditure per institution) showed overwhelmingly high proportions. However, cerebral palsy (36.03% of the total number of inpatient visits and 24.55% of the total number of inpatient patients) was a more important topic in inpatient clinical settings than musculoskeletal conditions or cancer, and healthcare expenditure per patient in this topic had the highest ranking. Furthermore, fractures were found to be highly important in inpatient clinical settings. No patients had influenza A virus infection or posttraumatic stress disorders who visited the KM medical institution of interest.</p><p><strong>Conclusion: </strong>This study highlights the gap between the real-world clinical setting and the research field in some topics. The results of this study can provide guidance for the second-wave development of KM-CPGs in the future.</p>","PeriodicalId":16769,"journal":{"name":"Journal of Pharmacopuncture","volume":"26 2","pages":"198-209"},"PeriodicalIF":1.4,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/34/jop-26-2-198.PMC10315883.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Pharmacopuncture
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1